Table 4.
1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospitalization rate per 1000 Patients with PE | ||||||||||||
Age | ||||||||||||
65–74 | 157.0 | 155.0 | 155.6 | 159.6 | 166.0 | 174.3 | 164.2 | 155.8 | 158.0 | 161.2 | 156.0 | 149.6 |
75–84 | 161.0 | 158.1 | 166.2 | 172.4 | 177.3 | 185.6 | 184.3 | 172.6 | 173.2 | 177.2 | 176.5 | 164.1 |
≥85 | 150.0 | 158.0 | 167.0 | 176.0 | 181.0 | 189.9 | 196.5 | 178.4 | 187.9 | 194.8 | 200.1 | 194.6 |
Sex | ||||||||||||
Female | 152.3 | 150.0 | 155.1 | 162.1 | 167.8 | 177.2 | 174.9 | 161.8 | 165.1 | 168.7 | 167.3 | 159.6 |
Male | 166.6 | 168.7 | 173.2 | 176.9 | 182.0 | 189.0 | 183.7 | 174.7 | 177.3 | 182.7 | 180.8 | 170.5 |
Race | ||||||||||||
Black | 204.7 | 195.7 | 208.3 | 204.1 | 197.6 | 219.7 | 200.7 | 188.8 | 192.4 | 195.3 | 193.8 | 182.3 |
White | 152.0 | 152.4 | 155.7 | 162.9 | 169.5 | 176.6 | 174.8 | 163.7 | 166.5 | 171.3 | 169.1 | 161.5 |
Other | 159.1 | 151.7 | 193.3 | 171.3 | 197.4 | 182.6 | 194.7 | 177.1 | 188.1 | 184.0 | 199.3 | 166.6 |
Adjusted 30-day mortality rate (%)* | ||||||||||||
65–74 | 12.4 | 12.3 | 13.2 | 11.4 | 12.7 | 12.4 | 11.5 | 12.0 | 10.9 | 11.1 | 11.6 | 9.6 |
75–84 | 13.3 | 13.5 | 13.0 | 13.1 | 13.1 | 13.9 | 12.1 | 11.4 | 11.5 | 11.8 | 12.5 | 11.7 |
≥85 | 15.8 | 14.9 | 14.2 | 14.4 | 15.3 | 14.9 | 13.9 | 11.8 | 12.3 | 13.5 | 11.8 | 12.8 |
Sex | ||||||||||||
Female | 12.3 | 12.5 | 11.8 | 11.4 | 12.2 | 12.9 | 11.4 | 10.5 | 10.5 | 11.1 | 11.2 | 10.1 |
Male | 15.1 | 14.6 | 15.7 | 14.7 | 15.1 | 14.3 | 13.5 | 13.5 | 12.9 | 13.1 | 13.0 | 12.9 |
Race | ||||||||||||
Black | 14.2 | 14.9 | 11.6 | 13.5 | 13.1 | 13.7 | 12.5 | 11.4 | 10.3 | 10.8 | 10.6 | 11.1 |
White | 13.2 | 13.2 | 13.7 | 12.6 | 13.4 | 13.4 | 12.3 | 11.7 | 11.7 | 12.0 | 12.2 | 11.1 |
Other | 18.0 | 11.6 | 11.5 | 11.5 | 12.7 | 15.1 | 9.2 | 11.3 | 9.5 | 10.6 | 11.6 | 11.3 |
Adjusted 1-year mortality rate (%)* | ||||||||||||
65–74 | 32.2 | 33.5 | 34.1 | 31.5 | 31.3 | 32.6 | 31.1 | 29.9 | 28.5 | 29.9 | 28.8 | 29.0 |
75–84 | 32.7 | 33.4 | 34.0 | 34.8 | 33.4 | 34.0 | 31.4 | 32.0 | 32.3 | 32.5 | 32.0 | 30.7 |
≥85 | 37.7 | 35.8 | 36.7 | 36.0 | 37.4 | 37.0 | 36.3 | 33.2 | 35.8 | 37.9 | 35.0 | 33.7 |
Sex | ||||||||||||
Female | 30.5 | 32.2 | 32.4 | 32.4 | 32.0 | 32.6 | 30.9 | 29.4 | 29.9 | 31.5 | 30.3 | 29.0 |
Male | 37.9 | 36.7 | 38.1 | 36.0 | 35.5 | 36.2 | 33.9 | 34.4 | 33.9 | 34.7 | 33.4 | 33.4 |
Race | ||||||||||||
Black | 34.4 | 34.2 | 34.8 | 37.2 | 34.6 | 34.4 | 34.6 | 31.8 | 31.6 | 34.4 | 32.8 | 31.1 |
White | 33.1 | 34.2 | 34.9 | 33.1 | 32.9 | 33.8 | 31.7 | 31.3 | 31.5 | 32.5 | 31.3 | 30.6 |
Other | 36.9 | 24.3 | 26.9 | 33.7 | 37.6 | 34.7 | 29.9 | 34.2 | 31.9 | 31.0 | 33.5 | 29.6 |
Adjusted for demographics and comorbidities (reference: 1999).
IVCF: inferior vena caval filter, PE: pulmonary embolism.